Ibnsina Pharma Co (ISPH)

Currency in EGP
12.630
+0.280(+2.27%)
Closed·
Earnings results expected in 13 days
ISPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.38012.880
52 wk Range
6.10013.720
Key Statistics
Bid/Ask
12.60 / 12.67
Prev. Close
12.63
Open
12.41
Day's Range
12.38-12.88
52 wk Range
6.1-13.72
Volume
9.4M
Average Volume (3m)
4.79M
1-Year Change
106.3725%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ISPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.033
Upside
+19.03%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Ibnsina Pharma Co Company Profile

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

Employees
5500
Market
Egypt

Compare ISPH to Peers and Sector

Metrics to compare
ISPH
Peers
Sector
Relationship
P/E Ratio
18.1x18.4x−0.5x
PEG Ratio
0.190.320.00
Price/Book
5.1x2.8x2.6x
Price / LTM Sales
0.2x1.3x3.3x
Upside (Analyst Target)
14.8%24.8%45.5%
Fair Value Upside
Unlock17.5%5.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.033
(+19.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.70%
Dividend Yield
1.27%
Industry Median 1.45%
Annualized payout
0.16
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Dec 03, 2025
EPS / Forecast
0.22 / --
Revenue / Forecast
20.35B / --
EPS Revisions
Last 90 days

ISPH Income Statement

People Also Watch

FAQ

What Is the Ibnsina Pharma (ISPH) Stock Price Today?

The Ibnsina Pharma stock price today is 12.630

What Stock Exchange Does Ibnsina Pharma Trade On?

Ibnsina Pharma is listed and trades on the Egypt Stock Exchange.

What Is the Stock Symbol for Ibnsina Pharma?

The stock symbol for Ibnsina Pharma is "ISPH."

Does Ibnsina Pharma Pay Dividends? What’s The Current Dividend Yield?

The Ibnsina Pharma dividend yield is 1.27%.

What Is the Ibnsina Pharma Market Cap?

As of today, Ibnsina Pharma market cap is 12.730B.

What Is Ibnsina Pharma's Earnings Per Share (TTM)?

The Ibnsina Pharma EPS (TTM) is 0.70.

When Is the Next Ibnsina Pharma Earnings Date?

Ibnsina Pharma will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is ISPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Ibnsina Pharma Stock Split?

Ibnsina Pharma has split 3 times.

How Many Employees Does Ibnsina Pharma Have?

Ibnsina Pharma has 5500 employees.

What is the current trading status of Ibnsina Pharma (ISPH)?

As of Feb 12, 2026, Ibnsina Pharma (ISPH) is trading at a price of 12.630, with a previous close of 12.630. The stock has fluctuated within a day range of 12.380 to 12.880, while its 52-week range spans from 6.100 to 13.720.

What Is Ibnsina Pharma (ISPH) Price Target According to Analysts?

The average 12-month price target for Ibnsina Pharma is EGP15.033, with a high estimate of EGP16.1 and a low estimate of EGP14.5. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.03% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.